Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19173 | 452 | 39.2 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 157 | 21931 | BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NKX31 | Author keyword | 20 | 59% | 5% | 23 |
| 2 | LOBUND | Address | 11 | 65% | 2% | 11 |
| 3 | 3 2 DIMETHYL 4 AMINOBIPHENYL | Author keyword | 11 | 69% | 2% | 9 |
| 4 | TRAMP | Author keyword | 4 | 16% | 4% | 20 |
| 5 | HOMEOBOX GENE NKX31 | Author keyword | 3 | 100% | 1% | 3 |
| 6 | PROSTATE SEMINAL VESICLE CANCER | Author keyword | 3 | 100% | 1% | 3 |
| 7 | PSP94 BETA MICROSEMINOPROTEIN | Author keyword | 3 | 100% | 1% | 3 |
| 8 | PROSTATE CANCER MODEL | Author keyword | 3 | 60% | 1% | 3 |
| 9 | PROSTATE CARCINOGENESIS | Author keyword | 3 | 26% | 2% | 9 |
| 10 | GEM MODELS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NKX31 | 20 | 59% | 5% | 23 | Search NKX31 | Search NKX31 |
| 2 | 3 2 DIMETHYL 4 AMINOBIPHENYL | 11 | 69% | 2% | 9 | Search 3+2+DIMETHYL+4+AMINOBIPHENYL | Search 3+2+DIMETHYL+4+AMINOBIPHENYL |
| 3 | TRAMP | 4 | 16% | 4% | 20 | Search TRAMP | Search TRAMP |
| 4 | HOMEOBOX GENE NKX31 | 3 | 100% | 1% | 3 | Search HOMEOBOX+GENE+NKX31 | Search HOMEOBOX+GENE+NKX31 |
| 5 | PROSTATE SEMINAL VESICLE CANCER | 3 | 100% | 1% | 3 | Search PROSTATE+SEMINAL+VESICLE+CANCER | Search PROSTATE+SEMINAL+VESICLE+CANCER |
| 6 | PSP94 BETA MICROSEMINOPROTEIN | 3 | 100% | 1% | 3 | Search PSP94+BETA+MICROSEMINOPROTEIN | Search PSP94+BETA+MICROSEMINOPROTEIN |
| 7 | PROSTATE CANCER MODEL | 3 | 60% | 1% | 3 | Search PROSTATE+CANCER+MODEL | Search PROSTATE+CANCER+MODEL |
| 8 | PROSTATE CARCINOGENESIS | 3 | 26% | 2% | 9 | Search PROSTATE+CARCINOGENESIS | Search PROSTATE+CARCINOGENESIS |
| 9 | GEM MODELS | 2 | 67% | 0% | 2 | Search GEM+MODELS | Search GEM+MODELS |
| 10 | PROBASIN | 2 | 22% | 1% | 6 | Search PROBASIN | Search PROBASIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HOMEOBOX GENE NKX31 | 20 | 66% | 4% | 19 |
| 2 | 8P21 | 19 | 76% | 3% | 13 |
| 3 | 3 2 DIMETHYL 4 AMINOBIPHENYL | 12 | 50% | 4% | 18 |
| 4 | L W RATS | 10 | 58% | 2% | 11 |
| 5 | CHROMOSOME 8P12 21 | 9 | 42% | 4% | 16 |
| 6 | LOBUND WISTAR RATS | 7 | 27% | 5% | 21 |
| 7 | TRAMP MODEL | 6 | 27% | 4% | 20 |
| 8 | PTEN MUTANT MICE | 5 | 55% | 1% | 6 |
| 9 | NKX31 | 4 | 24% | 4% | 16 |
| 10 | INVASIVE CARCINOMAS | 4 | 30% | 3% | 12 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A Review of the Existing Grading Schemes and a Proposal for a Modified Grading Scheme for Prostatic Lesions in TRAMP Mice | 2012 | 9 | 14 | 79% |
| Integrating differentiation and cancer: The Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis | 2008 | 46 | 82 | 49% |
| Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee | 2013 | 29 | 72 | 21% |
| Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee | 2004 | 293 | 91 | 22% |
| Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic | 2013 | 9 | 116 | 37% |
| Pten inactivation and the emergence of androgen-independent prostate cancer | 2007 | 69 | 31 | 26% |
| Mouse models of prostate cancer: picking the best model for the question | 2014 | 3 | 145 | 30% |
| Modeling Prostate Cancer in Mice: Limitations and Opportunities | 2012 | 12 | 83 | 35% |
| Current mouse and cell models in prostate cancer research | 2013 | 11 | 141 | 24% |
| Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasis | 2005 | 45 | 104 | 30% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LOBUND | 11 | 65% | 2.4% | 11 |
| 2 | ABORAT REPROD HLTH | 1 | 50% | 0.2% | 1 |
| 3 | BIOL MICROSCOPY MICROANAL | 1 | 50% | 0.2% | 1 |
| 4 | CELL REGULAT CARINOGENESIS | 1 | 50% | 0.2% | 1 |
| 5 | DISCOVERY STAT GRP | 1 | 50% | 0.2% | 1 |
| 6 | EUROL | 1 | 50% | 0.2% | 1 |
| 7 | FOOD COLOR | 1 | 50% | 0.2% | 1 |
| 8 | HEEKE ANIM DIS DIAGNOST | 1 | 50% | 0.2% | 1 |
| 9 | IFBLMU INTEGRATED TREATMENT VERTIGO | 1 | 50% | 0.2% | 1 |
| 10 | LI KU SHING | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000241130 | PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL |
| 2 | 0.0000163370 | LZTS1//UROGENE//NUCLEAR ROUNDNESS |
| 3 | 0.0000109347 | NORPEG//N COPINE//PSGR |
| 4 | 0.0000109228 | PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3 |
| 5 | 0.0000096860 | PROSTATIC INTRAEPITHELIAL NEOPLASIA//ATYPICAL SMALL ACINAR PROLIFERATION//ALPHA METHYLACYL COA RACEMASE |
| 6 | 0.0000096221 | NEUROENDOCRINE DIFFERENTIATION//SMALL CELL CARCINOMA//RENAL CARCINOID |
| 7 | 0.0000094039 | ANDROGEN RECEPTOR//ANDROGEN INSENSITIVITY SYNDROME//ANDROGEN INSENSITIVITY |
| 8 | 0.0000086743 | FOSFESTROL//IDIOPATHIC URETHRITIS//5 ALPHA ANDROSTANEDIOL |
| 9 | 0.0000072775 | UNIV INTEGRATED HOSP//DUKE PROSTATE//FREE TESTOSTERONE FT |
| 10 | 0.0000070646 | PEROPERATIVE BLEEDING//PRIMARY PROSTATE CULTURE//BLOOD VESSEL MORPHOLOGY |